CTXR
Citius Pharmaceuticals, Inc
Halal Rating :
See Details
Last Price
$0.68
Last updated:
Market Cap
$108.72m
7D Change
-1.55%
1 Year Change
-45.54%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
Dec. 21, 2023
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. The company is headquartered in Cranford, New Jersey.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Dec. 31, 2022 | $3.59m | $7.25m | $0.21 | $3.8m | 5.98% | 52.42% |
Company Impact
Help us evaluate Citius Pharmaceuticals, Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.